Wird geladen...
tPA Helpers in the Treatment of Acute Ischemic Stroke: Are They Ready for Clinical Use?
Tissue plasminogen activator (tPA) is the only therapeutic agent approved to treat patients with acute ischemic stroke. The clinical benefits of tPA manifest when the agent is administered within 4.5 hours of stroke onset. However, tPA administration, especially delayed administration, is associated...
Gespeichert in:
| Veröffentlicht in: | J Stroke |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Korean Stroke Society
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6549064/ https://ncbi.nlm.nih.gov/pubmed/31161761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5853/jos.2019.00584 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|